GRIGUOLO, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 223
EU - Europa 162
AS - Asia 145
SA - Sud America 39
OC - Oceania 30
AF - Africa 2
Totale 601
Nazione #
US - Stati Uniti d'America 176
NL - Olanda 56
SG - Singapore 56
CA - Canada 45
BR - Brasile 32
AU - Australia 30
FR - Francia 26
CN - Cina 21
DE - Germania 21
IN - India 21
GB - Regno Unito 18
VN - Vietnam 14
HK - Hong Kong 13
IT - Italia 9
RU - Federazione Russa 9
IR - Iran 7
TR - Turchia 7
ES - Italia 6
FI - Finlandia 4
AR - Argentina 3
AT - Austria 3
SE - Svezia 3
UA - Ucraina 3
CL - Cile 2
EC - Ecuador 2
IE - Irlanda 2
JP - Giappone 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CG - Congo 1
DJ - Gibuti 1
LV - Lettonia 1
MX - Messico 1
PA - Panama 1
PL - Polonia 1
Totale 601
Città #
Amsterdam 34
Singapore 28
Melbourne 26
Chevy Chase 25
Calgary 20
Lille 14
Hong Kong 13
Salvador 13
Ashburn 12
Paris 12
Beijing 10
Bethesda 10
Fairfield 10
Vancouver 10
Fonthill 9
Cambridge 8
Cardiff 8
Chapel Hill 8
Houston 8
Pasadena 8
Ulm 8
Istanbul 7
Sahāranpur 7
Seattle 7
Munich 6
New Delhi 6
Plymouth 6
Rotterdam 6
The Hague 6
Utrecht 6
Boardman 5
Ho Chi Minh City 5
San Francisco 5
Dos Hermanas 4
Frankfurt am Main 4
Indore 4
Los Angeles 4
Palm Desert 4
Santa Clara 4
Aylmerton 3
Buffalo 3
New York 3
Nuremberg 3
Stockholm 3
Wilmington 3
Woodbridge 3
Caxias do Sul 2
Dallas 2
Dong Ket 2
Dublin 2
Durham 2
Groningen 2
Haiphong 2
Hamilton 2
Hanoi 2
Hefei 2
Helsinki 2
Los Altos 2
Madrid 2
Medicina 2
Miami 2
Montreal 2
Princeton 2
Redondo Beach 2
Rome 2
Saint Paul 2
Seoul 2
St Petersburg 2
São Paulo 2
Tilburg 2
Tokyo 2
Tuscaloosa 2
Vienna 2
Waukesha 2
Abu Dhabi 1
Anicuns 1
Ann Arbor 1
Annapolis 1
Araxá 1
Atlanta 1
Bauru 1
Brookline 1
Capelinha 1
Cincinnati 1
Córdoba 1
Delhi 1
Divinópolis 1
Djibouti 1
Duque de Caxias 1
Fiesole 1
Fighiera 1
Guayaquil 1
Hyderabad 1
Joinville 1
Jundiaí 1
Kyiv 1
Lappeenranta 1
Lavras 1
Lucknow 1
Marília 1
Totale 493
Nome #
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 429
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements 74
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 64
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax 49
Totale 616
Categoria #
all - tutte 1.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 1 0 4 0 2 0 4
2021/202216 0 3 0 0 0 0 1 0 1 1 8 2
2022/20237 2 0 0 0 0 2 0 0 3 0 0 0
2023/202416 1 0 0 1 3 0 1 0 0 3 4 3
2024/2025112 6 8 8 3 4 5 6 7 13 15 18 19
2025/2026421 24 26 44 146 123 58 0 0 0 0 0 0
Totale 616